Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 09 March, 2025
Author: Getaka|Social: Getaka Financial Technology X (Earlier Twitter) Profile Getaka Financial Technology LinkedIn Logo
Stock Ticker - BSE: 514238 | NSE: MKVENTURES

MKVentures Capital Ltd: Share Price Analysis, Intrinsic Value & Fundamentals

Share Price and Basic Stock Data

Last Updated: March 7, 2025, 8:00 pm

Market Cap 564 Cr.
Current Price 1,468
High / Low 2,800/1,212
Stock P/E27.4
Book Value 267
Dividend Yield0.07 %
ROCE20.6 %
ROE33.6 %
Face Value 10.0
PEG Ratio0.55

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for

Competitors of

Stock Name Market Cap Current Price High / Low Stock P/E Book Value Dividend Yield ROCE ROE Face Value
MKVentures Capital Ltd 564 Cr. 1,468 2,800/1,21227.4 2670.07 %20.6 %33.6 % 10.0
Modern Shares & Stockbrokers Ltd 13.5 Cr. 46.0 69.4/30.038.5 43.90.00 %4.33 %3.24 % 10.0
Monarch Networth Capital Ltd 2,574 Cr. 328 501/22616.6 93.00.15 %51.8 %43.4 % 10.0
Monotype India Ltd 53.4 Cr. 0.76 2.42/0.546.69 0.130.00 %438 %% 1.00
Multipurpose Trading & Agencies Ltd 4.95 Cr. 10.0 13.3/7.8126.1 10.20.00 %4.44 %3.91 % 10.0
Industry Average6,184.21 Cr1,381.4077.275,211.950.35%18.12%16.77%7.38

All Competitor Stocks of

Quarterly Result

MetricDec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Sales 4.570.280.132.6614.0310.4712.599.608.448.417.656.827.86
Expenses 0.320.260.000.050.161.380.830.780.610.610.500.450.48
Operating Profit 4.250.020.132.6113.879.0911.768.827.837.807.156.377.38
OPM % 93.00%7.14%100.00%98.12%98.86%86.82%93.41%91.88%92.77%92.75%93.46%93.40%93.89%
Other Income 0.01-0.010.000.030.030.000.180.431.160.610.450.660.68
Interest 2.120.000.000.241.582.184.482.762.060.480.541.280.83
Depreciation 0.000.000.000.000.000.000.000.000.020.060.090.090.10
Profit before tax 2.140.010.132.4012.326.917.466.496.917.876.975.667.13
Tax % 82.24%-1,900.00%0.00%26.25%25.08%25.18%27.08%26.50%27.64%25.41%26.26%25.09%24.96%
Net Profit 0.380.210.131.779.235.185.444.775.015.875.144.235.35
EPS in Rs 1.000.550.344.6624.2913.6314.1512.4113.0315.2713.3711.0113.92

Last Updated: Unknown

Below is a detailed analysis of the quarterly data for MKVentures Capital Ltd: Share Price Analysis, Intrinsic Value & Fundamentals based on the most recent figures (Dec 2024) and their trends compared to the previous period:

  • For Sales, as of Dec 2024, the value is ₹7.86 Cr.. The value appears strong and on an upward trend. It has increased from 6.82 Cr. (Sep 2024) to ₹7.86 Cr., marking an increase of ₹1.04 Cr..
  • For Expenses, as of Dec 2024, the value is ₹0.48 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.45 Cr. (Sep 2024) to ₹0.48 Cr., marking an increase of ₹0.03 Cr..
  • For Operating Profit, as of Dec 2024, the value is ₹7.38 Cr.. The value appears strong and on an upward trend. It has increased from 6.37 Cr. (Sep 2024) to ₹7.38 Cr., marking an increase of ₹1.01 Cr..
  • For OPM %, as of Dec 2024, the value is 93.89%. The value appears strong and on an upward trend. It has increased from 93.40% (Sep 2024) to 93.89%, marking an increase of 0.49%.
  • For Other Income, as of Dec 2024, the value is ₹0.68 Cr.. The value appears strong and on an upward trend. It has increased from 0.66 Cr. (Sep 2024) to ₹0.68 Cr., marking an increase of ₹0.02 Cr..
  • For Interest, as of Dec 2024, the value is ₹0.83 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.28 Cr. (Sep 2024) to ₹0.83 Cr., marking a decrease of 0.45 Cr..
  • For Depreciation, as of Dec 2024, the value is ₹0.10 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.09 Cr. (Sep 2024) to ₹0.10 Cr., marking an increase of ₹0.01 Cr..
  • For Profit before tax, as of Dec 2024, the value is ₹7.13 Cr.. The value appears strong and on an upward trend. It has increased from 5.66 Cr. (Sep 2024) to ₹7.13 Cr., marking an increase of ₹1.47 Cr..
  • For Tax %, as of Dec 2024, the value is 24.96%. The value appears to be improving (decreasing) as expected. It has decreased from 25.09% (Sep 2024) to 24.96%, marking a decrease of 0.13%.
  • For Net Profit, as of Dec 2024, the value is ₹5.35 Cr.. The value appears strong and on an upward trend. It has increased from 4.23 Cr. (Sep 2024) to ₹5.35 Cr., marking an increase of ₹1.12 Cr..
  • For EPS in Rs, as of Dec 2024, the value is 13.92. The value appears strong and on an upward trend. It has increased from ₹11.01 (Sep 2024) to 13.92, marking an increase of ₹2.91.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 3:31 pm

MetricMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024TTM
Sales 91119397915312814274131
Expenses 9111938771491111232
Operating Profit 1-0012411813263929
OPM % 5%-0%2%1%3%2%42%37%91%94%94%93%93%
Other Income 000-000000-0002
Interest 00001212474103
Depreciation 0000000000000
Profit before tax 0-0-0-0110-136222928
Tax % 10%160%-67%-67%19%28%0%0%17%26%25%27%
Net Profit 0-0-0-011-0-135162121
EPS in Rs 0.50-0.34-0.03-0.052.052.37-0.16-3.877.1112.0342.8954.8553.57
Dividend Payout % 0%0%0%0%0%0%0%0%0%0%0%2%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year2017-20182018-20192020-20212021-20222022-20232023-2024
YoY Net Profit Growth (%)0.00%-100.00%400.00%66.67%220.00%31.25%
Change in YoY Net Profit Growth (%)0.00%-100.00%500.00%-333.33%153.33%-188.75%

has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 6 years from 2017-2018 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:14%
5 Years:101%
3 Years:71%
TTM:-25%
Compounded Profit Growth
10 Years:67%
5 Years:223%
3 Years:98%
TTM:1%
Stock Price CAGR
10 Years:57%
5 Years:139%
3 Years:25%
1 Year:-13%
Return on Equity
10 Years:28%
5 Years:36%
3 Years:42%
Last Year:34%

Last Updated: Unknown

Balance Sheet

Last Updated: Unknown

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Sep 2024
Equity Capital 3333333333344
Reserves 55556665812289099
Borrowings 0000000000249018
Other Liabilities 0000000010292036
Total Liabilities 88889101091216309114157
Fixed Assets 1000000000011
CWIP 0000000000000
Investments 000000847140120
Other Assets 78889102552309100156
Total Assets 88889101091216309114157

Below is a detailed analysis of the balance sheet data for MKVentures Capital Ltd: Share Price Analysis, Intrinsic Value & Fundamentals based on the most recent figures (Sep 2024) and their trends compared to the previous period:

  • For Equity Capital, as of Sep 2024, the value is ₹4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹4.00 Cr..
  • For Reserves, as of Sep 2024, the value is ₹99.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹90.00 Cr. (Mar 2024) to ₹99.00 Cr., marking an increase of 9.00 Cr..
  • For Borrowings, as of Sep 2024, the value is ₹18.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹0.00 Cr. (Mar 2024) to ₹18.00 Cr., marking an increase of 18.00 Cr..
  • For Other Liabilities, as of Sep 2024, the value is ₹36.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹20.00 Cr. (Mar 2024) to ₹36.00 Cr., marking an increase of 16.00 Cr..
  • For Total Liabilities, as of Sep 2024, the value is ₹157.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹114.00 Cr. (Mar 2024) to ₹157.00 Cr., marking an increase of 43.00 Cr..
  • For Fixed Assets, as of Sep 2024, the value is ₹1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹1.00 Cr..
  • For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
  • For Investments, as of Sep 2024, the value is ₹0.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹12.00 Cr. (Mar 2024) to ₹0.00 Cr., marking a decrease of 12.00 Cr..
  • For Other Assets, as of Sep 2024, the value is ₹156.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹100.00 Cr. (Mar 2024) to ₹156.00 Cr., marking an increase of 56.00 Cr..
  • For Total Assets, as of Sep 2024, the value is ₹157.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹114.00 Cr. (Mar 2024) to ₹157.00 Cr., marking an increase of 43.00 Cr..

Notably, the Reserves (₹99.00 Cr.) exceed the Borrowings (18.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Cash from Operating Activity +-1-3-0-04-1-1-4-5-0-259258
Cash from Investing Activity +110100154714-12
Cash from Financing Activity +-00-0-0-1-2000-7246-218
Net Cash Flow-1-2-013-301-1-0028

Free Cash Flow

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Free Cash Flow1.000.000.001.002.004.001.001.008.0013.00-223.0039.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthMar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
Debtor Days22310-000-0-0-0-0-0-0
Inventory Days12110698501319
Days Payable-0-0-00-0-0
Cash Conversion Cycle14313798501320-0-0-0-0-0-0
Working Capital Days125181119621820196325320-353-167
ROCE %5%-1%4%5%28%38%5%6%78%97%17%21%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthMar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
Promoters83.66%83.66%83.66%83.66%83.66%74.36%74.36%74.36%74.36%74.36%74.36%74.36%
FIIs0.00%0.00%0.00%0.00%0.06%4.26%4.26%4.26%4.26%4.26%4.26%4.26%
Public16.34%16.34%16.35%16.35%16.29%21.38%21.39%21.39%21.38%21.39%21.38%21.39%
No. of Shareholders1,3021,3091,3551,6122,0982,4182,9133,1142,9163,3573,6333,902

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE / ROE Trend

EPS Trend

Key Financial Ratios

MonthMar 24Mar 23
FaceValue 10.0010.00
Basic EPS (Rs.) 55.4647.91
Diluted EPS (Rs.) 55.4647.91
Cash EPS (Rs.) 55.2947.91
Book Value[Excl.RevalReserv]/Share (Rs.) 243.9593.22
Book Value[Incl.RevalReserv]/Share (Rs.) 243.9593.22
Revenue From Operations / Share (Rs.) 101.5479.99
PBDIT / Share (Rs.) 100.7175.66
PBIT / Share (Rs.) 100.5075.66
PBT / Share (Rs.) 75.0563.94
Net Profit / Share (Rs.) 55.0947.91
NP After MI And SOA / Share (Rs.) 55.0947.91
PBDIT Margin (%) 99.1894.58
PBIT Margin (%) 98.9894.58
PBT Margin (%) 73.9179.93
Net Profit Margin (%) 54.2559.89
NP After MI And SOA Margin (%) 54.2559.89
Return on Networth / Equity (%) 22.5851.39
Return on Capital Employeed (%) 40.6977.73
Return On Assets (%) 16.215.01
Total Debt / Equity (X) 0.007.81
Asset Turnover Ratio (%) 0.170.00
Current Ratio (X) 3.221.06
Quick Ratio (X) 3.221.06
Interest Coverage Ratio (X) 3.966.46
Interest Coverage Ratio (Post Tax) (X) 3.165.09
Enterprise Value (Cr.) 588.14630.60
EV / Net Operating Revenue (X) 15.0723.07
EV / EBITDA (X) 15.2024.40
MarketCap / Net Operating Revenue (X) 15.9114.11
Price / BV (X) 6.6212.11
Price / Net Operating Revenue (X) 15.9114.11
EarningsYield 0.030.04

After reviewing the key financial ratios for MKVentures Capital Ltd: Share Price Analysis, Intrinsic Value & Fundamentals, here is a detailed analysis based on the latest available data and recent trends:

  • For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
  • For Basic EPS (Rs.), as of Mar 24, the value is 55.46. This value is within the healthy range. It has increased from 47.91 (Mar 23) to 55.46, marking an increase of 7.55.
  • For Diluted EPS (Rs.), as of Mar 24, the value is 55.46. This value is within the healthy range. It has increased from 47.91 (Mar 23) to 55.46, marking an increase of 7.55.
  • For Cash EPS (Rs.), as of Mar 24, the value is 55.29. This value is within the healthy range. It has increased from 47.91 (Mar 23) to 55.29, marking an increase of 7.38.
  • For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 243.95. It has increased from 93.22 (Mar 23) to 243.95, marking an increase of 150.73.
  • For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 243.95. It has increased from 93.22 (Mar 23) to 243.95, marking an increase of 150.73.
  • For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 101.54. It has increased from 79.99 (Mar 23) to 101.54, marking an increase of 21.55.
  • For PBDIT / Share (Rs.), as of Mar 24, the value is 100.71. This value is within the healthy range. It has increased from 75.66 (Mar 23) to 100.71, marking an increase of 25.05.
  • For PBIT / Share (Rs.), as of Mar 24, the value is 100.50. This value is within the healthy range. It has increased from 75.66 (Mar 23) to 100.50, marking an increase of 24.84.
  • For PBT / Share (Rs.), as of Mar 24, the value is 75.05. This value is within the healthy range. It has increased from 63.94 (Mar 23) to 75.05, marking an increase of 11.11.
  • For Net Profit / Share (Rs.), as of Mar 24, the value is 55.09. This value is within the healthy range. It has increased from 47.91 (Mar 23) to 55.09, marking an increase of 7.18.
  • For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 55.09. This value is within the healthy range. It has increased from 47.91 (Mar 23) to 55.09, marking an increase of 7.18.
  • For PBDIT Margin (%), as of Mar 24, the value is 99.18. This value is within the healthy range. It has increased from 94.58 (Mar 23) to 99.18, marking an increase of 4.60.
  • For PBIT Margin (%), as of Mar 24, the value is 98.98. This value exceeds the healthy maximum of 20. It has increased from 94.58 (Mar 23) to 98.98, marking an increase of 4.40.
  • For PBT Margin (%), as of Mar 24, the value is 73.91. This value is within the healthy range. It has decreased from 79.93 (Mar 23) to 73.91, marking a decrease of 6.02.
  • For Net Profit Margin (%), as of Mar 24, the value is 54.25. This value exceeds the healthy maximum of 10. It has decreased from 59.89 (Mar 23) to 54.25, marking a decrease of 5.64.
  • For NP After MI And SOA Margin (%), as of Mar 24, the value is 54.25. This value exceeds the healthy maximum of 20. It has decreased from 59.89 (Mar 23) to 54.25, marking a decrease of 5.64.
  • For Return on Networth / Equity (%), as of Mar 24, the value is 22.58. This value is within the healthy range. It has decreased from 51.39 (Mar 23) to 22.58, marking a decrease of 28.81.
  • For Return on Capital Employeed (%), as of Mar 24, the value is 40.69. This value is within the healthy range. It has decreased from 77.73 (Mar 23) to 40.69, marking a decrease of 37.04.
  • For Return On Assets (%), as of Mar 24, the value is 16.21. This value is within the healthy range. It has increased from 5.01 (Mar 23) to 16.21, marking an increase of 11.20.
  • For Total Debt / Equity (X), as of Mar 24, the value is 0.00. This value is within the healthy range. It has decreased from 7.81 (Mar 23) to 0.00, marking a decrease of 7.81.
  • For Asset Turnover Ratio (%), as of Mar 24, the value is 0.17. It has increased from 0.00 (Mar 23) to 0.17, marking an increase of 0.17.
  • For Current Ratio (X), as of Mar 24, the value is 3.22. This value exceeds the healthy maximum of 3. It has increased from 1.06 (Mar 23) to 3.22, marking an increase of 2.16.
  • For Quick Ratio (X), as of Mar 24, the value is 3.22. This value exceeds the healthy maximum of 2. It has increased from 1.06 (Mar 23) to 3.22, marking an increase of 2.16.
  • For Interest Coverage Ratio (X), as of Mar 24, the value is 3.96. This value is within the healthy range. It has decreased from 6.46 (Mar 23) to 3.96, marking a decrease of 2.50.
  • For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 3.16. This value is within the healthy range. It has decreased from 5.09 (Mar 23) to 3.16, marking a decrease of 1.93.
  • For Enterprise Value (Cr.), as of Mar 24, the value is 588.14. It has decreased from 630.60 (Mar 23) to 588.14, marking a decrease of 42.46.
  • For EV / Net Operating Revenue (X), as of Mar 24, the value is 15.07. This value exceeds the healthy maximum of 3. It has decreased from 23.07 (Mar 23) to 15.07, marking a decrease of 8.00.
  • For EV / EBITDA (X), as of Mar 24, the value is 15.20. This value exceeds the healthy maximum of 15. It has decreased from 24.40 (Mar 23) to 15.20, marking a decrease of 9.20.
  • For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 15.91. This value exceeds the healthy maximum of 3. It has increased from 14.11 (Mar 23) to 15.91, marking an increase of 1.80.
  • For Price / BV (X), as of Mar 24, the value is 6.62. This value exceeds the healthy maximum of 3. It has decreased from 12.11 (Mar 23) to 6.62, marking a decrease of 5.49.
  • For Price / Net Operating Revenue (X), as of Mar 24, the value is 15.91. This value exceeds the healthy maximum of 3. It has increased from 14.11 (Mar 23) to 15.91, marking an increase of 1.80.
  • For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.04 (Mar 23) to 0.03, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of as of March 9, 2025 is: ₹1,967.86

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 9, 2025, is Undervalued by 34.05% compared to the current share price 1,468.00

Intrinsic Value of as of March 9, 2025 is: 2,947.17

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 9, 2025, is Undervalued by 100.76% compared to the current share price 1,468.00

Last 5 Year EPS CAGR: 49.77%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 25.25%, which is a positive sign.
  2. The stock has a low average Working Capital Days of 25.50, which is a positive sign.
  3. The company has higher reserves (21.54 cr) compared to borrowings (20.54 cr), indicating strong financial stability.
  4. The company has shown consistent growth in sales (33.38 cr) and profit (6.85 cr) over the years.
  1. The stock has a high average Cash Conversion Cycle of 38.42, which may not be favorable.
  • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in :
    1. Net Profit Margin: 54.25%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 40.69% (Industry Average ROCE: 18.12%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. ROE%: 22.58% (Industry Average ROE: 16.77%)
      • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
    4. Interest Coverage Ratio (Post Tax): 3.16
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    5. Quick Ratio: 3.22
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    6. Stock P/E: 27.4 (Industry average Stock P/E: 77.27)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    7. Total Debt / Equity: 0
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
    Stock Rating:

About the Company - Qualitative Analysis

Mkventures Capital Ltd. is a Public Limited Listed company incorporated on 17/01/1991 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L17100MH1991PLC059848 and registration number is 059848. Currently Company is involved in the business activities of Other financial service activities, except insurance and pension funding activities. Company's Total Operating Revenue is Rs. 39.03 Cr. and Equity Capital is Rs. 3.84 Cr. for the Year ended 31/03/2024.
INDUSTRYADDRESSCONTACT
Finance & Investments11th Floor, Express Towers, Mumbai Maharashtra 400021info@mkventurescapital.com
http://www.mkventurescapital.com
Management
NamePosition Held
Mr. Madhusudan Murlidhar KelaManaging Director
Mr. Sumit BhalotiaNon Executive Director
Mr. Sanjay MalpaniIndependent Director
Mr. Siddharth AgarwalIndependent Director
Mr. Rajeev AgarwalIndependent Director
Mrs. Shruti BahetyIndependent Director

FAQ

What is the latest intrinsic value of ?

The latest intrinsic value of as on 08 March 2025 is ₹1967.86, which is 34.05% higher than the current market price of 1,468.00, indicating the stock is undervalued by 34.05%. The intrinsic value of is calculated using PE ratio method. The stock has a market capitalization of ₹564 Cr. and recorded a high/low of ₹2,800/1,212 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹99 Cr and total liabilities of ₹157 Cr.

What is the Market Cap of ?

The Market Cap of is 564 Cr..

What is the current Stock Price of as on 08 March 2025?

The current stock price of as on 08 March 2025 is ₹1,468.

What is the High / Low of stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of stocks is ₹2,800/1,212.

What is the Stock P/E of ?

The Stock P/E of is 27.4.

What is the Book Value of ?

The Book Value of is 267.

What is the Dividend Yield of ?

The Dividend Yield of is 0.07 %.

What is the ROCE of ?

The ROCE of is 20.6 %.

What is the ROE of ?

The ROE of is 33.6 %.

What is the Face Value of ?

The Face Value of is 10.0.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in . Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE